1,3-Dioxoisoindolin-2-yl 4-fluorobenzoate

Catalog No. :
ACSPLB308
CAS No. :
305359-06-2
Molecular Formula :
C15H8FNO4
Molecular Weight :
285.23

IUPAC Name:1,3-dioxoisoindolin-2-yl 4-fluorobenzoate

1,3-Dioxoisoindolin-2-yl 4-fluorobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$160.00Login to see priceIn stockInquiry
10g98%$247.00Login to see priceIn stockInquiry
25g98%$587.00Login to see priceInquiryInquiry
100g98%$1976.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Dioxoisoindolin-2-yl 4-fluorobenzoate
IUPAC Name1,3-dioxoisoindolin-2-yl 4-fluorobenzoate
Molecular FormulaC15H8FNO4
Molecular Weight285.23
SMILESO=C(ON(C(C1=C2C=CC=C1)=O)C2=O)C3=CC=C(F)C=C3
InChI KeyZQEDOCXKSFRCGX-UHFFFAOYSA-N
SynonymBenzoic acid, 4-fluoro-, 1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl ester;1,3-Dioxoisoindolin-2-yl 4-fluorobenzoate;1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl 4-fluorobenzoate
CAS No.305359-06-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACSPLB308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWHOJ803 route compound structure diagram
    ACWHOJ803524-38-9 In Stock
  4. Then
  5. ACSPLB308 route product structure diagram
    ACSPLB308305359-06-2 In Stock
Inquiry

2. ACSPLB308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWHOJ803 route compound structure diagram
    ACWHOJ803524-38-9 In Stock
  4. Then
  5. ACSPLB308 route product structure diagram
    ACSPLB308305359-06-2 In Stock
Inquiry

Comments (0)